Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-13-044076
Filing Date
2013-05-23
Accepted
2013-05-23 06:51:31
Documents
7
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A a13-4096_320fa.htm 20-F/A 52188
  Complete submission text file 0001104659-13-044076.txt   10663444

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT sva-20121231.xml EX-101.INS 1756210
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sva-20121231.xsd EX-101.SCH 95872
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sva-20121231_cal.xml EX-101.CAL 102578
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sva-20121231_def.xml EX-101.DEF 413021
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sva-20121231_lab.xml EX-101.LAB 1391270
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sva-20121231_pre.xml EX-101.PRE 656707
Mailing Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Filer) CIK: 0001084201 (see all company filings)

EIN.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 0430
Type: 20-F/A | Act: 34 | File No.: 001-32371 | Film No.: 13866681
SIC: 2834 Pharmaceutical Preparations